https://www.uniccra.be/2026-05-05T14:28:18+00:00https://www.uniccra.be/meet-our-team/2024-01-31T14:38:59+00:00https://www.uniccra.be/patient-info/2024-02-06T20:33:22+00:00https://www.uniccra.be/phase1-clinical-trials/2026-05-29T08:55:48+00:00https://www.uniccra.be/professional-info/2024-01-31T15:20:13+00:00https://www.uniccra.be/meet-our-team/medical-oncologists/2026-04-15T17:21:13+00:00https://www.uniccra.be/meet-our-team/hematologists/2026-01-16T10:28:23+00:00https://www.uniccra.be/meet-our-team/research-team/2026-03-31T15:10:57+00:00https://www.uniccra.be/patient-info/patientenbrochures-uza/2023-10-06T13:13:10+00:00https://www.uniccra.be/patient-info/behandeling/2023-10-11T07:41:12+00:00https://www.uniccra.be/professional-info/chemotherapy-regimens/2025-01-15T15:32:32+00:00https://www.uniccra.be/professional-info/oncology-manual/2025-08-05T15:05:50+00:00https://www.uniccra.be/professional-info/presentations/2025-09-30T08:46:41+00:00https://www.uniccra.be/professional-info/cancer-genetics/2024-11-06T20:09:26+00:00https://www.uniccra.be/professional-info/recist/2023-10-25T09:52:19+00:00https://www.uniccra.be/professional-info/supportive-care/2025-10-23T13:46:28+00:00https://www.uniccra.be/news/2024-10-24T12:44:41+00:00https://www.uniccra.be/agenda/2023-11-12T18:59:23+00:00https://www.uniccra.be/tools-for-clinical-research/2023-10-25T09:51:05+00:00https://www.uniccra.be/hans-prenen/2023-12-19T19:36:30+00:00https://www.uniccra.be/timon-vandamme/2023-12-21T09:14:23+00:00https://www.uniccra.be/hypersensitivity-reactions/2025-09-30T08:27:51+00:00https://www.uniccra.be/jan-van-den-brande/2023-12-21T09:12:59+00:00https://www.uniccra.be/marika-rasschaert/2023-12-21T09:14:08+00:00https://www.uniccra.be/annelies-verbiest/2023-12-21T09:14:36+00:00https://www.uniccra.be/konstantinos-papadimitriou/2023-12-21T09:13:44+00:00https://www.uniccra.be/sevilay-altintas/2024-01-17T12:31:02+00:00https://www.uniccra.be/dr-laure-anne-teuwen/2024-01-31T14:53:39+00:00https://www.uniccra.be/bernd-dekeyser/2023-12-21T09:15:18+00:00https://www.uniccra.be/helena-oliveres/2023-12-21T09:15:29+00:00https://www.uniccra.be/prof-dr-annelies-janssens/2023-10-25T13:29:26+00:00https://www.uniccra.be/dr-jo-raskin/2023-10-25T13:32:32+00:00https://www.uniccra.be/dr-reinier-wener/2023-10-25T13:33:07+00:00https://www.uniccra.be/dr-willem-lybaert/2023-12-21T09:15:45+00:00https://www.uniccra.be/prof-dr-vibeke-kruse/2024-01-11T14:14:56+00:00https://www.uniccra.be/dr-yanina-dockx/2023-10-25T13:33:28+00:00https://www.uniccra.be/dr-hans-dedecker/2024-01-16T11:18:58+00:00https://www.uniccra.be/jan-van-meerbeeck/2023-12-19T19:37:37+00:00https://www.uniccra.be/donate/2025-08-21T15:53:57+00:00https://www.uniccra.be/breast-cancer-chemotherapy-regimens/2025-01-30T15:56:03+00:00https://www.uniccra.be/sebastien-anguille/2023-12-19T19:37:10+00:00https://www.uniccra.be/digestive-oncology-chemotherapy-regimens/2026-02-20T20:51:34+00:00https://www.uniccra.be/aflibercept/2025-01-29T17:02:25+00:00https://www.uniccra.be/atezolizumab-bevacizumab/2025-01-29T17:02:57+00:00https://www.uniccra.be/bevacizumab-crc/2025-01-29T17:03:22+00:00https://www.uniccra.be/capecitabine-crc/2025-01-29T17:04:47+00:00https://www.uniccra.be/capecitabine-oxaliplatin/2025-01-29T17:03:43+00:00https://www.uniccra.be/capecitabine-temozolomide/2025-01-29T17:04:11+00:00https://www.uniccra.be/carboplatin-paclitaxel-slokdarm/2025-01-29T17:05:19+00:00https://www.uniccra.be/cetuximab-crc/2025-01-29T17:05:42+00:00https://www.uniccra.be/cisplatin-gemicitabine-durvalumab/2025-01-29T17:06:08+00:00https://www.uniccra.be/cisplatin-modified-degramont/2025-01-29T17:06:44+00:00https://www.uniccra.be/cisplatin-of-carboplatin-etoposide-net/2025-01-29T17:10:32+00:00https://www.uniccra.be/docetaxel-dio/2025-01-29T17:11:13+00:00https://www.uniccra.be/everolimus-net/2025-01-29T17:11:38+00:00https://www.uniccra.be/flot/2025-01-29T17:17:05+00:00https://www.uniccra.be/gemcitabine-pancreas/2025-01-29T17:13:47+00:00https://www.uniccra.be/gemcitabine-nab-paclitaxel/2025-01-29T17:12:38+00:00https://www.uniccra.be/gemox/2023-12-08T15:03:55+00:00https://www.uniccra.be/lenvatinib-hcc/2025-01-29T17:14:17+00:00https://www.uniccra.be/mfolfiri/2025-01-29T17:14:38+00:00https://www.uniccra.be/mfolfirinox/2025-01-29T17:14:59+00:00https://www.uniccra.be/mfolfox/2025-01-29T17:15:18+00:00https://www.uniccra.be/mitomycine-5fu-rt/2025-01-29T17:15:42+00:00https://www.uniccra.be/naliri-5fu/2025-01-29T17:16:05+00:00https://www.uniccra.be/nivolumab-ge/2025-01-29T17:16:43+00:00https://www.uniccra.be/paclitaxel-ramucirumab/2025-01-29T17:17:36+00:00https://www.uniccra.be/panitumumab-crc/2025-01-29T17:17:59+00:00https://www.uniccra.be/pembrolizumab-ge/2025-01-29T17:18:31+00:00https://www.uniccra.be/pemetrexed-cisplatin/2025-01-29T17:08:42+00:00https://www.uniccra.be/pemigatinib/2025-01-29T17:18:55+00:00https://www.uniccra.be/regorafenib/2025-01-29T17:20:46+00:00https://www.uniccra.be/sorafenib-hcc/2025-01-29T17:21:14+00:00https://www.uniccra.be/sunitinib-net/2025-01-29T17:21:32+00:00https://www.uniccra.be/tas102-lonsurf/2025-01-29T17:21:52+00:00https://www.uniccra.be/tomudex-oxaliplatin/2025-01-29T17:19:29+00:00https://www.uniccra.be/trastuzumab-ge/2025-01-29T17:22:18+00:00https://www.uniccra.be/tremelimumab-durvalumab/2025-01-29T17:22:42+00:00https://www.uniccra.be/dpd-deficiency/2023-12-08T16:56:55+00:00https://www.uniccra.be/iron-deficiency/2023-12-08T16:56:00+00:00https://www.uniccra.be/anal-cancer/2025-12-10T10:08:37+00:00https://www.uniccra.be/esophageal-cancer/2025-12-10T10:10:38+00:00https://www.uniccra.be/clinical-trials/2025-11-18T12:30:34+00:00https://www.uniccra.be/digestive-oncology-trials/2026-05-29T12:32:15+00:00https://www.uniccra.be/neuro-oncology-chemotherapy-regimens/2025-10-09T10:53:53+00:00https://www.uniccra.be/cisplatin-vincristine-cyclofosfamide-packer/2024-11-27T11:51:14+00:00https://www.uniccra.be/lomustine/2023-12-19T18:55:30+00:00https://www.uniccra.be/procarbazine-lomustine-vincristine-pcv/2024-11-27T11:52:19+00:00https://www.uniccra.be/temozolomide/2024-10-24T09:14:15+00:00https://www.uniccra.be/vincristine/2024-11-27T11:51:53+00:00https://www.uniccra.be/vismodegib/2023-12-21T09:11:46+00:00https://www.uniccra.be/gastric-cancer/2025-12-10T10:11:09+00:00https://www.uniccra.be/chemotherapy-induced-nausea-and-vomiting/2023-12-19T19:22:37+00:00https://www.uniccra.be/breast-oncology-trials/2026-05-28T12:10:53+00:00https://www.uniccra.be/gynaecological-oncology-trials/2026-03-17T08:04:39+00:00https://www.uniccra.be/head-and-neck-oncology-trials/2026-02-24T10:34:04+00:00https://www.uniccra.be/genito-urinary-oncology-trials/2026-03-26T07:49:09+00:00https://www.uniccra.be/neuro-oncology-trials/2026-03-26T11:45:40+00:00https://www.uniccra.be/soft-tissue-tumor-trials/2025-10-14T14:23:47+00:00https://www.uniccra.be/neuro-endocrine-tumor-trials/2025-11-20T14:47:20+00:00https://www.uniccra.be/lung-cancer-trials/2026-05-21T09:20:04+00:00https://www.uniccra.be/useful-websites/2024-01-11T16:30:22+00:00https://www.uniccra.be/dermatologic-oncology-chemotherapy-regimens/2025-10-09T10:45:50+00:00https://www.uniccra.be/avelumab/2024-10-30T14:08:23+00:00https://www.uniccra.be/dabrafenib-trametinib/2024-01-14T17:19:04+00:00https://www.uniccra.be/ipilimumab-nivolumab/2024-10-30T14:09:34+00:00https://www.uniccra.be/ipilimumab/2024-10-30T14:11:23+00:00https://www.uniccra.be/nivolumab/2024-10-24T14:34:23+00:00https://www.uniccra.be/pembrolizumab/2024-10-24T14:36:32+00:00https://www.uniccra.be/vismodegib-2/2024-01-14T17:22:32+00:00https://www.uniccra.be/lomustine-bevacizumab/2024-01-14T17:31:11+00:00https://www.uniccra.be/temozolomide-bevacizumab/2024-10-24T09:13:42+00:00https://www.uniccra.be/pancreas-richtlijnen-belgie-fapa-2021/2024-01-15T14:19:22+00:00https://www.uniccra.be/uza-folder-erfelijke-borst-eierstok-en-eileiderkanker/2024-01-15T14:19:55+00:00https://www.uniccra.be/artikels-i-v-m-somatische-varianten-germline-focused-analysis/2024-01-15T14:22:12+00:00https://www.uniccra.be/dr-vincent-geldhof/2024-01-17T19:46:42+00:00https://www.uniccra.be/oral-mucositis/2024-01-29T20:32:06+00:00https://www.uniccra.be/head-and-neck-oncology-chemotherapy-regimens/2025-05-20T14:02:18+00:00https://www.uniccra.be/carboplatin-cetuximab/2024-01-31T17:46:40+00:00https://www.uniccra.be/carboplatin-docetaxel-fluorouracil/2025-12-10T12:10:57+00:00https://www.uniccra.be/carboplatin-fluorouracil-cetuximab/2025-12-10T12:11:14+00:00https://www.uniccra.be/carboplatin-fluorouracil-pembrolizumab/2025-12-10T12:11:33+00:00https://www.uniccra.be/carboplatin-fluorouracil-rt/2025-12-10T12:11:55+00:00https://www.uniccra.be/carboplatin-fluorouracil-zonder-rt/2025-12-10T12:12:18+00:00https://www.uniccra.be/carboplatin-paclitaxel-cetuximab/2025-12-10T12:12:36+00:00https://www.uniccra.be/carboplatin-rt/2025-12-10T12:13:09+00:00https://www.uniccra.be/carboplatin-auc-2-paclitaxel-135/2025-12-10T12:13:37+00:00https://www.uniccra.be/carboplatin-auc-6-paclitaxel-175/2025-12-10T12:14:04+00:00https://www.uniccra.be/cetuximab/2024-11-27T11:57:47+00:00https://www.uniccra.be/cisplatin-rt/2025-12-10T11:58:44+00:00https://www.uniccra.be/cisplatin-75-paclitaxel-175/2024-11-27T11:58:15+00:00https://www.uniccra.be/cisplatin-75-paclitaxel-175-cetuximab/2024-11-27T11:58:42+00:00https://www.uniccra.be/cisplatin-100-fluorouracil/2025-03-07T10:02:16+00:00https://www.uniccra.be/cisplatin-100-fluorouracil-cetuximab/2025-03-07T10:02:37+00:00https://www.uniccra.be/cisplatin-100-fluororuacil-pembrolizumab/2025-12-10T12:00:59+00:00https://www.uniccra.be/docetaxel-cisplatin-fluorouracil/2025-05-20T13:59:22+00:00https://www.uniccra.be/docetaxel-cisplatin-fluorouracil-cetuximab/2025-05-20T14:00:16+00:00https://www.uniccra.be/nivolumab-nko/2024-01-31T17:58:11+00:00https://www.uniccra.be/pembrolizumab-nko/2024-01-31T17:58:49+00:00https://www.uniccra.be/search/2025-10-14T14:41:49+00:00https://www.uniccra.be/capecitabine-metronomic/2024-11-27T11:57:24+00:00https://www.uniccra.be/study-specific-documents/2024-08-23T07:51:53+00:00https://www.uniccra.be/head-and-neck-cancer/2024-03-22T16:42:58+00:00https://www.uniccra.be/renal-cell-cancer/2024-03-22T16:50:10+00:00https://www.uniccra.be/gynaecological-oncology-chemotherapy-regimens/2026-01-26T10:36:57+00:00https://www.uniccra.be/abemaciclib/2025-10-30T14:01:00+00:00https://www.uniccra.be/capecitabine/2024-11-27T12:49:03+00:00https://www.uniccra.be/carboplatin-gemcitabine-pembrolizumab/2024-10-03T14:24:52+00:00https://www.uniccra.be/carboplatin-vinorelbine/2025-04-30T13:44:39+00:00https://www.uniccra.be/carboplatin-paclitaxel-wekelijks/2025-07-02T15:34:32+00:00https://www.uniccra.be/carboplatin-docetaxel-trastuzumab-sc-pertuzumab/2025-02-18T11:15:52+00:00https://www.uniccra.be/cisplatin-vinorelbine/2025-04-30T13:52:32+00:00https://www.uniccra.be/docetaxel-cyclofosfamide/2024-10-03T14:27:05+00:00https://www.uniccra.be/docetaxel-wekelijks/2024-10-03T14:27:46+00:00https://www.uniccra.be/docetaxel-driewekelijks/2024-10-03T14:28:21+00:00https://www.uniccra.be/doxorubicine-cyclofosfamide-ac/2024-10-15T11:52:15+00:00https://www.uniccra.be/doxorubicine-gepegyleerd-liposomaal/2024-10-03T14:31:14+00:00https://www.uniccra.be/epirubicine-cyclofosfamide-ec/2024-10-03T14:31:41+00:00https://www.uniccra.be/epirubicine-wekelijks/2024-10-03T14:32:15+00:00https://www.uniccra.be/eribuline/2025-04-17T14:47:56+00:00https://www.uniccra.be/everolimus-exemestane/2024-10-03T14:34:28+00:00https://www.uniccra.be/fulvestrant/2024-10-03T14:34:55+00:00https://www.uniccra.be/lapatinib-capecitabine/2024-10-03T14:35:24+00:00https://www.uniccra.be/letrozole/2024-10-03T14:37:06+00:00https://www.uniccra.be/mitomycine-intrahepatisch/2024-10-03T14:38:00+00:00https://www.uniccra.be/olaparib/2024-11-27T12:50:53+00:00https://www.uniccra.be/paclitaxel-gemcitabine/2025-01-15T16:08:32+00:00https://www.uniccra.be/paclitaxel/2025-07-02T15:35:03+00:00https://www.uniccra.be/palbociclib/2024-10-03T14:40:06+00:00https://www.uniccra.be/pembrolizumab-2/2024-10-03T14:40:34+00:00https://www.uniccra.be/ribociclib/2025-12-10T12:16:06+00:00https://www.uniccra.be/sacituzumab-govitecan/2025-03-13T14:41:35+00:00https://www.uniccra.be/talazoparib/2024-10-03T14:41:51+00:00https://www.uniccra.be/trastuzumab-capecitabine-tucatinib/2024-10-03T14:42:27+00:00https://www.uniccra.be/trastuzumab-pertuzumab/2024-10-03T14:42:55+00:00https://www.uniccra.be/trastuzumab-deruxtecan/2024-10-03T14:43:20+00:00https://www.uniccra.be/trastuzumab-emtansine/2024-10-03T14:43:49+00:00https://www.uniccra.be/trastuzumab/2024-10-03T14:44:14+00:00https://www.uniccra.be/vinorelbine/2024-10-03T14:44:39+00:00https://www.uniccra.be/methotrexaat-cyclofosfamide/2024-10-03T14:37:33+00:00https://www.uniccra.be/actinomycine-gtn/2024-11-27T11:10:41+00:00https://www.uniccra.be/bevacizumab-ov/2024-03-24T19:57:02+00:00https://www.uniccra.be/carboplatin-doxorubicine-gepegyleerd-liposomaal-ov/2024-11-27T10:56:29+00:00https://www.uniccra.be/carboplatin-gemcitabine-ov/2024-11-27T10:58:11+00:00https://www.uniccra.be/carboplatin-gemcitabine-bevacizumab-ov/2024-11-27T10:58:53+00:00https://www.uniccra.be/carboplatin-paclitaxel-bevacizumab-pembrolizumab-cerv/2024-11-27T10:59:32+00:00https://www.uniccra.be/carboplatin-2-7-paclitaxel-60-ov-end-cerv/2024-03-24T19:59:16+00:00https://www.uniccra.be/carboplatin-q1w-paclitaxel-q1w-ov/2024-11-27T11:00:34+00:00https://www.uniccra.be/carboplatin-q1w-paclitaxel-q1w-bevacizumab-ov/2024-11-27T11:01:16+00:00https://www.uniccra.be/carboplatin-q3w-bevacizumab-ov/2024-11-27T11:04:17+00:00https://www.uniccra.be/carboplatin-q3w-paclitaxel-q3w-ov-end/2024-11-06T12:14:49+00:00https://www.uniccra.be/carboplatin-q3w-paclitaxel-q3w-bevacizumab-ov/2024-11-27T11:05:06+00:00https://www.uniccra.be/carboplatin-q3w-paclitaxel-q3w-dostarlimab-mnp-end/2024-11-27T11:05:45+00:00https://www.uniccra.be/cemiplimab-cerv/2024-03-24T20:03:17+00:00https://www.uniccra.be/cisplatin-doxorubicin-end/2024-11-27T11:06:24+00:00https://www.uniccra.be/cisplatin-fluorouracil-vulv/2024-11-27T11:06:55+00:00https://www.uniccra.be/cisplatin-gemcitabine-bevacizumab-ov/2024-11-27T11:07:41+00:00https://www.uniccra.be/cisplatin-paclitaxel-bevacizumab-cerv/2024-11-27T11:08:27+00:00https://www.uniccra.be/cisplatin-paclitaxel-bevacizumab-pembrolizumab-cerv/2024-11-27T11:09:10+00:00https://www.uniccra.be/cisplatin-q3w-cerv/2024-03-24T20:06:22+00:00https://www.uniccra.be/cisplatin-rt-cerv/2025-05-20T14:05:02+00:00https://www.uniccra.be/cisplatin-rt-carboplatin-paclitaxel-end/2024-11-27T11:10:10+00:00https://www.uniccra.be/doxorubicine-end/2024-10-15T15:01:20+00:00https://www.uniccra.be/doxorubicine-gepegyleerd-liposomaal-ov/2024-10-15T15:02:58+00:00https://www.uniccra.be/doxorubicine-gepegyleerd-liposomaal-bevacizumab-ov/2024-10-15T15:01:54+00:00https://www.uniccra.be/doxorubicine-gepegyleerd-liposomaal-trabectedin-ov/2024-11-27T11:11:18+00:00https://www.uniccra.be/ema-co-gtn/2025-01-16T12:54:10+00:00https://www.uniccra.be/methotrexaat-im-gtn/2024-10-15T15:03:25+00:00https://www.uniccra.be/niraparib-ov/2024-03-25T09:05:23+00:00https://www.uniccra.be/olaparib-ov/2024-03-25T09:05:45+00:00https://www.uniccra.be/paclitaxel-end/2024-03-25T09:06:07+00:00https://www.uniccra.be/pembrolizumab-end/2024-03-25T09:06:53+00:00https://www.uniccra.be/topotecan-ov/2024-11-06T12:31:12+00:00https://www.uniccra.be/topotecan-bevacizumab-ov/2024-11-06T12:32:15+00:00https://www.uniccra.be/trastuzumab-mnp-end/2024-10-15T15:04:29+00:00https://www.uniccra.be/pembrolizumab-lenvatinib-end/2024-10-15T15:03:53+00:00https://www.uniccra.be/study-specific-documents-contact/2026-01-15T07:20:44+00:00https://www.uniccra.be/study-specific-documents-contract/2025-06-18T11:09:14+00:00https://www.uniccra.be/study-specific-documents-certificates/2025-08-05T07:26:09+00:00https://www.uniccra.be/study-specific-documents-aanmeldingsprocedure-epd/2024-07-09T18:45:53+00:00https://www.uniccra.be/study-specific-documents-certificates-investigators/2024-07-09T18:46:35+00:00https://www.uniccra.be/certificates-investigators-studies-breast-and-gyn/2025-07-16T18:48:52+00:00https://www.uniccra.be/certificates-investigators-studies-gi/2025-05-28T09:36:27+00:00https://www.uniccra.be/certificates-investigators-studies-head-and-neck/2025-05-28T09:36:47+00:00https://www.uniccra.be/certificates-investigators-studies-thoracic-oncology/2025-05-12T14:09:03+00:00https://www.uniccra.be/certificates-investigators-all-other-studies/2025-05-28T09:34:09+00:00https://www.uniccra.be/certificates-others/2025-08-05T07:27:53+00:00https://www.uniccra.be/iata-certificates/2026-05-27T07:15:20+00:00https://www.uniccra.be/faq-feasibility/2024-07-09T18:57:51+00:00https://www.uniccra.be/genito-urinary-oncology-chemotherapy-regimens/2025-12-10T11:09:20+00:00https://www.uniccra.be/abiraterone/2024-07-16T18:19:47+00:00https://www.uniccra.be/apalutamide/2025-01-08T17:00:53+00:00https://www.uniccra.be/avelumab-2/2024-10-30T14:07:59+00:00https://www.uniccra.be/axitinib/2025-01-08T17:01:32+00:00https://www.uniccra.be/axitinib-pembrolizumab/2024-07-16T18:22:29+00:00https://www.uniccra.be/bleomycine-etoposide-cisplatin/2025-01-16T12:50:57+00:00https://www.uniccra.be/cabazitaxel/2025-01-08T17:01:56+00:00https://www.uniccra.be/cabozantinib/2024-07-16T18:24:04+00:00https://www.uniccra.be/cabozantinib-nivolumab/2024-07-16T18:24:34+00:00https://www.uniccra.be/carboplatin/2024-07-16T18:25:44+00:00https://www.uniccra.be/carboplatin-gemcitabine/2025-01-08T16:39:01+00:00https://www.uniccra.be/carboplatin-q1w-paclitaxel-q1w/2024-07-16T18:26:54+00:00https://www.uniccra.be/cisplatin-gemcitabine/2024-07-16T18:27:25+00:00https://www.uniccra.be/cisplatin-split-gemcitabine/2024-07-16T18:29:57+00:00https://www.uniccra.be/darolutamide/2025-01-08T17:02:31+00:00https://www.uniccra.be/ddmvac/2025-01-08T16:41:36+00:00https://www.uniccra.be/docetaxel/2024-07-16T18:31:45+00:00https://www.uniccra.be/enfortumab-vedotin/2025-12-10T11:08:03+00:00https://www.uniccra.be/enzalutamide/2025-01-08T17:00:07+00:00https://www.uniccra.be/etoposide-ifosfamide-cisplatin/2024-07-16T18:33:24+00:00https://www.uniccra.be/everolimus/2024-07-16T18:33:54+00:00https://www.uniccra.be/gemcitabine-oxaliplatin/2025-01-29T17:13:12+00:00https://www.uniccra.be/ipilimumab-nivolumab-2/2024-10-30T14:10:30+00:00https://www.uniccra.be/nivolumab-2/2024-07-16T18:35:27+00:00https://www.uniccra.be/olaparib-2/2024-07-16T18:36:03+00:00https://www.uniccra.be/paclitaxel-ifosfamide-cisplatin/2024-10-30T13:58:56+00:00https://www.uniccra.be/pazopanib/2025-01-08T17:04:10+00:00https://www.uniccra.be/pembrolizumab-3/2024-07-16T18:37:33+00:00https://www.uniccra.be/pembrolizumab-lenvatinib/2025-01-08T17:04:40+00:00https://www.uniccra.be/sunitinib/2024-07-16T18:38:28+00:00https://www.uniccra.be/vinblastine-ifosfamide-cisplatin/2025-01-15T14:10:39+00:00https://www.uniccra.be/endocrine-tumors-chemotherapy-regimens/2025-01-15T14:21:23+00:00https://www.uniccra.be/cabozantinib-2/2024-07-18T18:32:04+00:00https://www.uniccra.be/etoposide-doxorubicine-cisplatin-mitotaan/2025-01-16T12:51:38+00:00https://www.uniccra.be/lenvatinib/2024-07-18T18:31:47+00:00https://www.uniccra.be/selpercatinib/2024-10-17T13:47:02+00:00https://www.uniccra.be/sorafenib/2024-07-18T18:31:32+00:00https://www.uniccra.be/vandetanib/2024-07-18T18:30:56+00:00https://www.uniccra.be/chemotherapy-induced-thrombocytopenia/2024-08-15T14:38:08+00:00https://www.uniccra.be/sops/2026-04-29T14:28:46+00:00https://www.uniccra.be/testicular-cancer/2024-08-23T08:12:18+00:00https://www.uniccra.be/sorafenib-2/2024-08-23T08:40:25+00:00https://www.uniccra.be/cyclofosfamide-doxorubicine-cisplatin/2025-12-10T12:01:56+00:00https://www.uniccra.be/cisplatin-80-gemcitabine/2025-12-10T12:03:18+00:00https://www.uniccra.be/cisplatin-80-gemcitabine-pembrolizumab/2024-11-27T11:59:50+00:00https://www.uniccra.be/endometrial-cancer/2026-02-22T10:02:38+00:00https://www.uniccra.be/cervical-cancer/2025-03-11T12:16:55+00:00https://www.uniccra.be/sarcoma-chemotherapy-regimens/2026-01-07T14:03:30+00:00https://www.uniccra.be/carboplatin-doxorubicine/2025-01-08T16:24:17+00:00https://www.uniccra.be/cisplatin-doxorubicine/2025-01-08T16:24:40+00:00https://www.uniccra.be/dacarbazine/2025-01-08T16:25:01+00:00https://www.uniccra.be/docetaxel-gemcitabine/2025-01-15T16:19:33+00:00https://www.uniccra.be/doxorubicine-ifosfamide-aim-60-6/2025-01-29T10:53:33+00:00https://www.uniccra.be/doxorubicine-ifosfamide-aim-75-10/2025-01-08T16:25:50+00:00https://www.uniccra.be/doxorubicine-gepegyleerd-liposomaal-2/2025-01-08T16:26:14+00:00https://www.uniccra.be/doxorubicine/2025-01-08T16:26:38+00:00https://www.uniccra.be/eribuline-2/2025-04-17T14:47:19+00:00https://www.uniccra.be/etoposide-ifosfamide-ewing-sarcoom/2025-02-26T14:55:42+00:00https://www.uniccra.be/etoposide-ifosfamide-weke-delen-sarcoom/2025-01-29T11:59:23+00:00https://www.uniccra.be/etoposide-ifosfamide-cisplatin-vip/2024-10-02T18:53:27+00:00https://www.uniccra.be/ifosfamide-3-dagen/2025-01-29T10:35:36+00:00https://www.uniccra.be/ifosfamide-5-dagen/2025-01-29T10:35:57+00:00https://www.uniccra.be/methotrexaat/2025-01-08T16:28:46+00:00https://www.uniccra.be/paclitaxel-2/2025-01-08T16:29:13+00:00https://www.uniccra.be/pazopanib-2/2024-10-03T07:17:19+00:00https://www.uniccra.be/temozolomide-irinotecan/2025-01-08T16:29:41+00:00https://www.uniccra.be/trabectedine-24u/2025-01-29T10:39:19+00:00https://www.uniccra.be/vincristine-cyclofosfamide-vc/2025-01-08T16:30:03+00:00https://www.uniccra.be/vincristine-doxorubicine-cyclofosfamide-vdc/2025-01-08T16:30:25+00:00https://www.uniccra.be/cisplatin-etoposide/2025-12-10T11:59:57+00:00https://www.uniccra.be/bevacizumab/2024-10-03T14:45:17+00:00https://www.uniccra.be/ipilimumab-nivolumab-flip/2024-11-06T17:08:05+00:00https://www.uniccra.be/opdualag/2024-11-27T11:50:35+00:00https://www.uniccra.be/encorafenib-binimetinib/2024-11-27T11:49:51+00:00https://www.uniccra.be/sonidegib/2024-11-06T17:09:45+00:00https://www.uniccra.be/tebentafusp/2024-11-27T11:48:59+00:00https://www.uniccra.be/gliomas/2025-10-09T11:00:15+00:00https://www.uniccra.be/lynch-richtlijnen-belgie-fapa-2020/2024-11-06T20:09:04+00:00https://www.uniccra.be/pancreatic-cancer/2025-12-10T10:12:23+00:00https://www.uniccra.be/glossary/2024-11-08T07:47:51+00:00https://www.uniccra.be/carboplatin-paclitaxel-durvalumab-olaparib/2024-11-27T11:47:33+00:00https://www.uniccra.be/cholangiocarcinoma/2025-12-10T10:09:18+00:00https://www.uniccra.be/rectal-cancer/2025-12-10T10:12:55+00:00https://www.uniccra.be/colon-cancer/2025-12-10T10:10:00+00:00https://www.uniccra.be/melanoma/2024-12-11T12:13:47+00:00https://www.uniccra.be/hepatocellular-carcinoma/2025-12-10T10:11:46+00:00https://www.uniccra.be/doxorubicine-trabectedine/2025-01-29T10:56:28+00:00https://www.uniccra.be/carboplatin-mcrpc/2025-01-08T16:46:06+00:00https://www.uniccra.be/chemotherapy-induced-neutropenia/2025-01-15T09:53:18+00:00https://www.uniccra.be/bleomycine-etoposide-carboplatin/2025-01-16T12:50:36+00:00https://www.uniccra.be/gemcitabine-capecitabine/2025-01-15T16:23:11+00:00https://www.uniccra.be/thoracic-oncology-chemotherapy-regimens/2025-12-10T11:53:27+00:00https://www.uniccra.be/afatinib/2025-04-30T08:15:31+00:00https://www.uniccra.be/alectinib/2025-04-30T08:16:00+00:00https://www.uniccra.be/atezolizumab/2025-04-30T08:16:25+00:00https://www.uniccra.be/brigatinib/2025-04-30T08:16:59+00:00https://www.uniccra.be/carboplatin-etoposide/2025-04-30T08:44:41+00:00https://www.uniccra.be/carboplatin-etoposide-atezolizumab/2025-04-30T08:22:05+00:00https://www.uniccra.be/carboplatin-etoposide-durvalumab/2025-04-30T08:44:23+00:00https://www.uniccra.be/carboplatin-gemcitabine-2/2025-04-30T08:48:39+00:00https://www.uniccra.be/carboplatin-gemcitabine-nivolumab-ipilimumab/2025-04-30T08:47:38+00:00https://www.uniccra.be/carboplatin-paclitaxel/2025-04-30T09:20:12+00:00https://www.uniccra.be/carboplatin-paclitaxel-atezolizumab-bevacizumab/2025-04-30T08:50:23+00:00https://www.uniccra.be/carboplatin-paclitaxel-nivolumab/2025-04-30T08:52:35+00:00https://www.uniccra.be/carboplatin-paclitaxel-nivolumab-ipilimumab/2025-04-30T08:51:41+00:00https://www.uniccra.be/carboplatin-paclitaxel-pembrolizumab/2025-04-30T08:53:31+00:00https://www.uniccra.be/carboplatin-pemetrexed/2025-01-15T15:47:39+00:00https://www.uniccra.be/carboplatin-pemetrexed-nivolumab/2025-04-30T13:32:04+00:00https://www.uniccra.be/carboplatin-pemetrexed-nivolumab-ipilimumab/2025-04-30T09:22:24+00:00https://www.uniccra.be/carboplatin-pemetrexed-pembrolizumab/2025-04-30T13:32:37+00:00https://www.uniccra.be/cisplatin-etoposide-2/2025-04-30T14:02:00+00:00https://www.uniccra.be/cisplatin-etoposide-atezolizumab/2025-01-16T12:59:45+00:00https://www.uniccra.be/cisplatin-etoposide-durvalumab/2025-04-30T14:00:49+00:00https://www.uniccra.be/cisplatin-gemcitabine-2/2025-04-30T14:22:33+00:00https://www.uniccra.be/cisplatin-gemcitabine-nivolumab/2025-04-30T14:21:37+00:00https://www.uniccra.be/cisplatin-pemetrexed/2025-04-30T13:46:24+00:00https://www.uniccra.be/cisplatin-pemetrexed-nivolumab/2025-04-30T13:45:36+00:00https://www.uniccra.be/cisplatin-vinorelbine-2/2025-04-30T13:51:21+00:00https://www.uniccra.be/crizotinib/2025-04-30T14:23:00+00:00https://www.uniccra.be/dabrafenib-trametinib-2/2025-04-30T14:23:41+00:00https://www.uniccra.be/docetaxel-2/2025-04-30T14:25:08+00:00https://www.uniccra.be/durvalumab/2025-04-30T14:26:51+00:00https://www.uniccra.be/entrectinib/2025-04-30T14:27:36+00:00https://www.uniccra.be/erlotinib/2025-04-30T14:27:59+00:00https://www.uniccra.be/gefinitib/2025-04-30T14:28:32+00:00https://www.uniccra.be/gemcitabine/2025-04-30T14:33:14+00:00https://www.uniccra.be/ipilimumab-nivolumab-3/2025-04-30T14:34:47+00:00https://www.uniccra.be/larotrectinib/2025-04-30T14:35:07+00:00https://www.uniccra.be/lorlatinib/2025-04-30T14:35:27+00:00https://www.uniccra.be/nivolumab-3/2025-04-30T14:35:51+00:00https://www.uniccra.be/osimertinib/2025-04-30T14:36:15+00:00https://www.uniccra.be/pembrolizumab-4/2025-04-30T14:36:43+00:00https://www.uniccra.be/pemetrexed/2025-04-30T14:38:52+00:00https://www.uniccra.be/pemetrexed-pembrolizumab/2025-04-30T14:37:22+00:00https://www.uniccra.be/selpercatinib-2/2025-04-30T14:39:15+00:00https://www.uniccra.be/temozolomide-2/2025-04-30T14:39:38+00:00https://www.uniccra.be/topotecan/2025-04-30T14:41:20+00:00https://www.uniccra.be/vinorelbine-2/2025-04-30T14:42:17+00:00https://www.uniccra.be/elacestrant/2025-01-30T15:55:41+00:00https://www.uniccra.be/mirvetuximab-soravtansine-mnp/2025-03-20T08:15:01+00:00https://www.uniccra.be/ovarian-cancer/2026-02-22T10:02:25+00:00https://www.uniccra.be/contamination-and-extravasation/2025-03-28T15:55:22+00:00https://www.uniccra.be/vaccinatiekaartje/2025-11-03T08:44:26+00:00https://www.uniccra.be/vaccinations/2025-03-27T14:38:35+00:00https://www.uniccra.be/carboplatin-paclitaxel-wekelijks-2/2025-12-10T12:14:27+00:00https://www.uniccra.be/carboplatin-q3w-paclitaxel-q1w/2025-07-02T15:38:15+00:00https://www.uniccra.be/cutaneous-oncology-trials/2025-10-14T14:16:53+00:00https://www.uniccra.be/ich-gcp-e6r3/2025-07-16T18:03:55+00:00https://www.uniccra.be/certificates-investigators-breast-gynaecological-studies-e6r3/2026-02-04T09:08:20+00:00https://www.uniccra.be/certificates-investigators-digestive-oncology-studies-e6r3/2026-02-04T09:07:50+00:00https://www.uniccra.be/certificates-investigators-studies-head-and-neck-e6r3/2026-02-04T09:08:33+00:00https://www.uniccra.be/certificates-investigators-studies-thoracic-oncology-e6r3/2025-11-04T09:07:47+00:00https://www.uniccra.be/certificates-studycoordinators-studynurse-ctas-e6r3/2026-05-28T11:14:42+00:00https://www.uniccra.be/certificates-investigators-all-other-studies-e6r3/2026-02-04T09:08:10+00:00https://www.uniccra.be/certificates-investigators-e6r3/2025-08-05T07:18:08+00:00https://www.uniccra.be/studies-melanoma/2026-02-04T09:08:01+00:00https://www.uniccra.be/bladder-cancer/2025-08-05T15:07:29+00:00https://www.uniccra.be/egfri-induced-skin-toxicity/2025-08-05T15:22:41+00:00https://www.uniccra.be/cemiplimab/2025-10-09T10:45:41+00:00https://www.uniccra.be/vorasidenib/2025-10-09T10:53:46+00:00https://www.uniccra.be/cyclofosfamide/2025-10-09T11:07:28+00:00https://www.uniccra.be/respiratory-oncologists/2026-04-03T13:40:39+00:00https://www.uniccra.be/oncologic-gynaecologists/2026-04-03T13:40:00+00:00https://www.uniccra.be/bone-targeted-agents-in-oncology/2025-10-23T13:46:01+00:00https://www.uniccra.be/dr-julie-verhaegen/2026-01-16T10:54:48+00:00https://www.uniccra.be/prrt-clinical-trials/2025-11-20T14:47:51+00:00https://www.uniccra.be/fruquintinib/2025-12-10T10:21:40+00:00https://www.uniccra.be/sox-bevacizumab/2025-12-10T10:50:19+00:00https://www.uniccra.be/trastuzumab-deruxtecan-2/2025-12-10T10:51:28+00:00https://www.uniccra.be/cisplatin-gemcitabine-pembrolizumab-cholangio/2025-12-10T10:52:28+00:00https://www.uniccra.be/tegafur-gimeracil-oteracil-teysuno/2025-12-10T10:53:41+00:00https://www.uniccra.be/enfortumab-vedotin-pembrolizumab/2025-12-10T11:08:42+00:00https://www.uniccra.be/hithoc/2025-12-10T11:53:00+00:00https://www.uniccra.be/esmo-2025-highlights/2025-12-10T13:22:41+00:00https://www.uniccra.be/nirogacestat-stalen/2026-01-07T14:03:07+00:00https://www.uniccra.be/prof-dr-trinh-xuan-bich-gynaecologisch-oncoloog/2026-01-16T10:55:30+00:00https://www.uniccra.be/dr-ann-van-de-velde/2026-01-16T10:14:34+00:00https://www.uniccra.be/rucaparib/2026-01-26T10:36:28+00:00https://www.uniccra.be/ivosidenib/2026-02-20T20:50:58+00:00